VeriMomVeriMom

tranexamoyl sh-pentapeptide-12 sp은 임신 중 안전한가요?

No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR safety assessment specifically for "tranexamoyl sh‑pentapeptide‑12 sp" identified, and no peer‑reviewed reproductive toxicity data were found indicating teratogenicity or reproductive hazard for the peptide conjugate. Parent compound (tranexamic acid) has systemic pharmacology when dosed systemically but topical cosmetic use of peptide conjugates offers negligible systemic exposure in the absence of data to the contrary (sources searched: ECHA Annex VI, SCCS/CIR, PubMed, PubChem/CosIng).

성분
tranexamoyl sh-pentapeptide-12 sp
알려진 위험 없음
100
/100
0

Related ingredients

Frequently asked questions

tranexamoyl sh-pentapeptide-12 sp은 임신 중 안전한가요?
No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR safety assessment specifically for "tranexamoyl sh‑pentapeptide‑12 sp" identified, and no peer‑reviewed reproductive toxicity data were found indicating teratogenicity or reproductive hazard for the peptide conjugate. Parent compound (tranexamic acid) has systemic pharmacology when dosed systemically but topical cosmetic use of peptide conjugates offers negligible systemic exposure in the absence of data to the contrary (sources searched: ECHA Annex VI, SCCS/CIR, PubMed, PubChem/CosIng).
tranexamoyl sh-pentapeptide-12 sp은 모유 수유 중 안전한가요?
No data indicating reproductive or lactation hazard for this cosmetic peptide. No harmonised hazard classification or SCCS/CIR opinion found. Given expected minimal dermal absorption of a peptide conjugate from cosmetic use, systemic exposure via breastmilk is unlikely.
tranexamoyl sh-pentapeptide-12 sp은 아기 피부에 안전한가요?
No infant‑specific toxicology identified. Hazard and mechanism: no evidence of developmental or endocrine activity for the peptide conjugate. Exposure: infant skin has higher relative absorption and immature barrier—so exposure score increased by +1 versus adult (from 0 to 1) despite expectation of low systemic absorption for the topical peptide.
VeriMom은 tranexamoyl sh-pentapeptide-12 sp을 어떻게 평가하나요?
VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 tranexamoyl sh-pentapeptide-12 sp을 100/100 (알려진 위험 없음)로 평가합니다.
임신 중 tranexamoyl sh-pentapeptide-12 sp 대체 안전 성분은?
유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.

모든 성분표를 2초 만에 확인

VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.

의료 면책 조항

이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.

VeriMom 앱에서 모든 기능을 이용해 보세요